Summary
Human embryonic stem cells (hESC) have the potential to treat a wide range of diseases. Currently, the use of existing hESC lines in human clinical applications is limited, as they are derived from blastocysts subjected to immunosurgery with animal derived antibodies, and are maintained on mouse embryonic feeder (MEF) cells, in the presence of either fetal calf serum (FCS) or on Matrigel or with conditioned media from MEFs. Successful derivation of hESCs in xeno-free conditions is crucial in advancing stem cell therapy applications. Two hESC lines, one from chromosomally abnormal embryos and another cell line from normal embryos from the inner cell mass of human blastocysts are derived using a culture media that had 20% serum replacement (SR) and human FGF2 on human foreskin fibroblasts as feeder cells. Derivation and characterization of such xenofree hESCs suitable for clinical studies is described in this chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Martin MJ, Muotri A, Gage F et al. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 2005: 11: 228–32
Inzunza J, Sahlen S, Holmberg K et al. Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation. Mol Hum Reprod 2004: 10: 461–6.
Drukker M, Katchman H, Katz G et al. Human embryonic stem cells and their differentiated derivatives are less susceptible for immune rejection than adult cells. Stem Cells 2006: 24: 221–9.
Li Y, Powell S, Brunette E et al. Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol Bioeng 2005: 91: 688–98.
Rajasekhar, V.K. and Vemuri. M.C. Molecular insights into the function, fate, and prospects of stem cells. Stem Cells 2005: 23: 1212–20.
Inzunza J, Gertow K, Stromberg MA et al. Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells 2005: 23: 544–9.
Munne S, Marquez C, Magli C et al. Scoring criteria for preimplantation genetic diagnosis of numerical abnormalities for chromosomes X, Y, 13, 16, 18 and 21. Mol Hum Reprod 1998: 4: 863–70.
Yao S, Chen S, Clark J et al. Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc Natl Acad Sci USA 2006: 103: 6907–12.
Munne S, Magli C, Bahce M et al. Preimplantation diagnosis of the aneuploidies most commonly found in spontaneous abortions and live births: XY, 13, 14, 15, 16, 18, 21, 22. Prenat Diagn 1998: 18: 1459–66.
Munne S. Velilla E, Colls P et al. Self-correction of chromosomally abnormal embroys in culture and implications for stem cell production. Fertil Steril. 2005: 84: 1328–34.
Acknowledgment
The authors thank Mary Lynn Tilkins for helpful comments and suggestions.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press
About this protocol
Cite this protocol
Vemuri, M.C., Schimmel, T., Colls, P., Munne, S., Cohen, J. (2007). Derivation of Human Embryonic Stem Cells in Xeno-Free Conditions. In: Vemuri, M.C. (eds) Stem Cell Assays. Methods in Molecular Biology™, vol 407. Humana Press. https://doi.org/10.1007/978-1-59745-536-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-59745-536-7_1
Publisher Name: Humana Press
Print ISBN: 978-1-58829-744-0
Online ISBN: 978-1-59745-536-7
eBook Packages: Springer Protocols